Molecular properties that influence the oral bioavailability of drug candidates - PubMed
- ️Tue Jan 01 2002
. 2002 Jun 6;45(12):2615-23.
doi: 10.1021/jm020017n.
Affiliations
- PMID: 12036371
- DOI: 10.1021/jm020017n
Molecular properties that influence the oral bioavailability of drug candidates
Daniel F Veber et al. J Med Chem. 2002.
Abstract
Oral bioavailability measurements in rats for over 1100 drug candidates studied at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) have allowed us to analyze the relative importance of molecular properties considered to influence that drug property. Reduced molecular flexibility, as measured by the number of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of molecular weight. That on average both the number of rotatable bonds and polar surface area or hydrogen bond count tend to increase with molecular weight may in part explain the success of the molecular weight parameter in predicting oral bioavailability. The commonly applied molecular weight cutoff at 500 does not itself significantly separate compounds with poor oral bioavailability from those with acceptable values in this extensive data set. Our observations suggest that compounds which meet only the two criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area equal to or less than 140 A(2) (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat. Data sets for the artificial membrane permeation rate and for clearance in the rat were also examined. Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a negative effect on the permeation rate. A threshold permeation rate is a prerequisite of oral bioavailability. The rotatable bond count does not correlate with the data examined here for the in vivo clearance rate in the rat.
Similar articles
-
O' Donovan DH, De Fusco C, Kuhnke L, Reichel A. O' Donovan DH, et al. J Med Chem. 2023 Feb 23;66(4):2347-2360. doi: 10.1021/acs.jmedchem.2c01577. Epub 2023 Feb 8. J Med Chem. 2023. PMID: 36752336 Review.
-
Lu JJ, Crimin K, Goodwin JT, Crivori P, Orrenius C, Xing L, Tandler PJ, Vidmar TJ, Amore BM, Wilson AG, Stouten PF, Burton PS. Lu JJ, et al. J Med Chem. 2004 Nov 18;47(24):6104-7. doi: 10.1021/jm0306529. J Med Chem. 2004. PMID: 15537364
-
Fouché M, Schäfer M, Berghausen J, Desrayaud S, Blatter M, Piéchon P, Dix I, Martin Garcia A, Roth HJ. Fouché M, et al. ChemMedChem. 2016 May 19;11(10):1048-59. doi: 10.1002/cmdc.201600082. Epub 2016 May 6. ChemMedChem. 2016. PMID: 27154275
-
Time-related differences in the physical property profiles of oral drugs.
Leeson PD, Davis AM. Leeson PD, et al. J Med Chem. 2004 Dec 2;47(25):6338-48. doi: 10.1021/jm049717d. J Med Chem. 2004. PMID: 15566303
-
Orally Absorbed Cyclic Peptides.
Nielsen DS, Shepherd NE, Xu W, Lucke AJ, Stoermer MJ, Fairlie DP. Nielsen DS, et al. Chem Rev. 2017 Jun 28;117(12):8094-8128. doi: 10.1021/acs.chemrev.6b00838. Epub 2017 May 25. Chem Rev. 2017. PMID: 28541045 Review.
Cited by
-
Jurin M, Čikoš A, Stepanić V, Górecki M, Pescitelli G, Kontrec D, Jakas A, Dražić T, Roje M. Jurin M, et al. Pharmaceuticals (Basel). 2024 Sep 24;17(10):1259. doi: 10.3390/ph17101259. Pharmaceuticals (Basel). 2024. PMID: 39458900 Free PMC article.
-
Bandaru NR, Makam P, Akshinthala P, Katari NK, Banoth V, Kolli B, Gundla R. Bandaru NR, et al. Molecules. 2022 Nov 7;27(21):7647. doi: 10.3390/molecules27217647. Molecules. 2022. PMID: 36364469 Free PMC article.
-
Solution-phase parallel synthesis of a multisubstituted cyclic imidate library.
Mehta S, Waldo JP, Neuenswander B, Lushington GH, Larock RC. Mehta S, et al. ACS Comb Sci. 2013 May 13;15(5):247-54. doi: 10.1021/co3001605. Epub 2013 Apr 4. ACS Comb Sci. 2013. PMID: 23514214 Free PMC article.
-
Lee S, Esteva-Font C, Phuan PW, Anderson MO, Verkman AS. Lee S, et al. Medchemcomm. 2015;6:1278-1284. doi: 10.1039/C5MD00198F. Medchemcomm. 2015. PMID: 26191399 Free PMC article.
-
Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases.
Mustière R, Dassonville-Klimpt A, Sonnet P. Mustière R, et al. Future Med Chem. 2024 Jul 2;16(13):1357-1373. doi: 10.1080/17568919.2024.2359361. Epub 2024 Jun 10. Future Med Chem. 2024. PMID: 39109436 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources